A guide to the composition and functions of the extracellular matrix

NK Karamanos, AD Theocharis, Z Piperigkou… - The FEBS …, 2021 - Wiley Online Library
Extracellular matrix (ECM) is a dynamic 3‐dimensional network of macromolecules that
provides structural support for the cells and tissues. Accumulated knowledge clearly …

The unique properties of IgG4 and its roles in health and disease

T Rispens, MG Huijbers - Nature Reviews Immunology, 2023 - nature.com
IgG4 is the least abundant subclass of IgG in human serum and has unique functional
features. IgG4 is largely unable to activate antibody-dependent immune effector responses …

Phage display derived monoclonal antibodies: from bench to bedside

MA Alfaleh, HO Alsaab, AB Mahmoud… - Frontiers in …, 2020 - frontiersin.org
Monoclonal antibodies (mAbs) have become one of the most important classes of
biopharmaceutical products, and they continue to dominate the universe of …

Therapeutic strategies for thrombosis: new targets and approaches

N Mackman, W Bergmeier, GA Stouffer… - Nature reviews Drug …, 2020 - nature.com
Antiplatelet agents and anticoagulants are a mainstay for the prevention and treatment of
thrombosis. However, despite advances in antithrombotic therapy, a fundamental challenge …

The era of thromboinflammation: platelets are dynamic sensors and effector cells during infectious diseases

L Guo, MT Rondina - Frontiers in immunology, 2019 - frontiersin.org
Platelets are anucleate cells produced by megakaryocytes. In recent years, a robust body of
literature supports the evolving role of platelets as key sentinel and effector cells in infectious …

Autopsy findings in 32 patients with COVID-19: a single-institution experience

SS Elsoukkary, M Mostyka, A Dillard, DR Berman… - Pathobiology, 2021 - karger.com
Background: A novel coronavirus, SARS-CoV-2, was identified in Wuhan, China in late
2019. This virus rapidly spread around the world causing disease ranging from minimal …

[HTML][HTML] Recombinant ADAMTS13 for hereditary thrombotic thrombocytopenic purpura

LM Asmis, A Serra, A Krafft, A Licht… - … England Journal of …, 2022 - Mass Medical Soc
A 27-year-old patient with a history of severe obstetrical complications and arterial
thrombosis received a diagnosis of hereditary thrombotic thrombocytopenic purpura (TTP) …

Redefining outcomes in immune TTP: an international working group consensus report

A Cuker, SR Cataland, P Coppo… - Blood, The Journal …, 2021 - ashpublications.org
Immune-mediated thrombotic thrombocytopenic purpura (iTTP) is a potentially fatal
thrombotic microangiopathy caused by autoantibody-mediated severe deficiency of …

Platelet activation mechanisms and consequences of immune thrombocytopenia

S Sun, RT Urbanus, H Ten Cate, PG de Groot… - Cells, 2021 - mdpi.com
Autoimmune disorders are often associated with low platelet count or thrombocytopenia. In
immune-induced thrombocytopenia (IIT), a common mechanism is increased platelet …

Recombinant ADAMTS13 in congenital thrombotic thrombocytopenic purpura

M Scully, A Antun, SR Cataland, P Coppo… - … England Journal of …, 2024 - Mass Medical Soc
Background Congenital thrombotic thrombocytopenic purpura (TTP) results from severe
hereditary deficiency of ADAMTS13. The efficacy and safety of recombinant ADAMTS13 and …